179 related articles for article (PubMed ID: 16750344)
1. Medium-term follow-up data after sentinel node biopsy alone for breast cancer.
Haid A; Knauer M; Köberle-Wührer R; Ammann K; Koller L; Eiter H; Lang A; Wenzl E
Eur J Surg Oncol; 2006 Dec; 32(10):1180-5. PubMed ID: 16750344
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
4. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
5. [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
Giard S; Chauvet MP; Houpeau JL; Baranzelli MC; Carpentier P; Fournier C; Belkacemi Y; Bonneterre J
Gynecol Obstet Fertil; 2005 Apr; 33(4):213-9. PubMed ID: 15894205
[TBL] [Abstract][Full Text] [Related]
6. [Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital].
Cserni G; Rajtár M; Boross G; Sinkó M; Svébis M; Baltás B; Ambrózay E; Szúcs M
Orv Hetil; 2002 Mar; 143(9):437-46. PubMed ID: 12013684
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
Roumen RM; Kuijt GP; Liem IH; van Beek MW
Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
[TBL] [Abstract][Full Text] [Related]
8. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.
Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J;
Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935
[TBL] [Abstract][Full Text] [Related]
9. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study.
Knauer M; Konstantiniuk P; Haid A; Wenzl E; Riegler-Keil M; Pöstlberger S; Reitsamer R; Schrenk P
J Clin Oncol; 2006 Jul; 24(21):3374-80. PubMed ID: 16849751
[TBL] [Abstract][Full Text] [Related]
10. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
11. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
12. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
13. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
[TBL] [Abstract][Full Text] [Related]
14. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases].
Meijer S; Torrenga H; van der Sijp JR
Ned Tijdschr Geneeskd; 2002 May; 146(20):942-6. PubMed ID: 12051063
[TBL] [Abstract][Full Text] [Related]
15. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
16. [Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis].
Bézu C; Coutant C; Antoine M; Moutafoff C; Guillo E; Daraï E; Rouzier R; Uzan S
Gynecol Obstet Fertil; 2009; 37(7-8):604-10. PubMed ID: 19577499
[TBL] [Abstract][Full Text] [Related]
17. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
18. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of sentinel node biopsy in the previously treated breast.
Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]